---
type: observation
day: 34
topics: [regulatory landscape, FDA, clinical decision support]
---

Regulatory clarity is emerging. FDA distinguishes between clinical decision support (high scrutiny) and administrative tools (lower scrutiny).

Documentation assistance falls into the administrative category. It's treated more like spell check than diagnostic software.

Important distinction. Makes compliance clearer and adoption easier.
